SpectrumDNA, Inc. (SPXA)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
SpectrumDNA, Inc. (SPXA) trades at $0.01 with AI Score 54/100 (Grade B). Spectrum DNA, Inc. operates a social media studio, creating digital networked applications for media outlets and brand advertisers. Market cap: $580,956, Sector: Financial services.
Price live · AI analysis from Mar 17, 2026Analyst Coverage for SPXA: SPXA does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates SPXA against Financial Services peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
SPXA: 2/6 perspectives are bullish. Dominant signal: Izzy Englander bullish.
How is this calculated? →SpectrumDNA, Inc. (SPXA) Financial Services Profile
Spectrum DNA, Inc., a financial conglomerate, focuses on developing digital engagement platforms for media and advertising. The company's 'enginets,' including The Addictionary and PlanetTagger, aim to enhance user interaction and social media marketing. With a small team, SPXA navigates the competitive landscape of digital application development.
What Is the Investment Thesis for SPXA?
Spectrum DNA, Inc. presents a high-risk, high-reward investment profile due to its focus on digital engagement platforms and its presence in the competitive social media and advertising technology space. With a market capitalization of 581K and a negative P/E ratio of -0.24, the company's financial performance indicates significant challenges. However, its high gross margin of 97.1% suggests potential for profitability if revenue can be scaled effectively. Key value drivers include the successful adoption and monetization of its 'enginets,' particularly The Addictionary and PlanetTagger. Growth catalysts involve expanding its client base among media outlets and brand advertisers. Potential risks include intense competition, limited resources, and the need for continuous innovation to maintain relevance in the rapidly evolving digital landscape.
Based on FMP financials and quantitative analysis
SPXA Key Highlights
- Market Cap of 581K indicates the company is a micro-cap stock with high growth potential but also significant risk.
- P/E Ratio of -0.24 reflects the company's current lack of profitability, suggesting it is not yet generating positive earnings.
- Gross Margin of 97.1% highlights the company's ability to efficiently manage its direct costs, indicating strong potential for profitability if revenue increases.
- Beta of -16.81 suggests the stock price moves inversely and more drastically than the market, indicating high volatility.
- Profit Margin of -1392.5% demonstrates significant losses relative to revenue, underscoring the need for improved operational efficiency and revenue generation.
Who Are SPXA's Competitors?
SPXA is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| AMLTF AMP Limited | $1.05 | +0.00% | $2.55B | 62 |
| PHLLF Petershill Partners PLC | $4.13 | +0.07% | $4.47B | 59 |
| APLMW Apollomics, Inc. | $0.02 | +15.15% | $280.82M | 59 |
| ACOG Alpha Cognition Inc. | $7.96 | +0.89% | $123.63M | 58 |
| TREE LendingTree, Inc. | $45.30 | +0.67% | $632.11M | 54 |
| RILYN B. Riley Financial, Inc. - 6.50 | $24.96 | -0.04% | $320.63M | 54 |
| PACS PACS Group, Inc. | $44.85 | +0.84% | $7.10B | 55 |
| MSDL Morgan Stanley Direct Lending Fund | $15.41 | +0.10% | $1.31B | 53 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are SPXA's Key Strengths?
- Proprietary 'enginet' technology
- Integrated social marketing platform
- Customizable browser application
- API for gamification integration
What Are SPXA's Weaknesses?
- Limited financial resources
- Small team size
- Negative profitability
- High dependence on key clients
What Could Drive SPXA Stock Higher?
- Expansion of 'enginet' applications to cater to a broader range of media outlets and brand advertisers.
- Strategic partnerships with media outlets to provide access to a larger audience and increased brand visibility.
- Development of AI-powered engagement tools to enhance the functionality and effectiveness of Spectrum DNA's enginets (2-3 years).
- Geographic expansion into emerging markets to tap into the growing demand for digital engagement platforms (3-5 years).
What Are the Key Risks for SPXA?
- Intense competition from established players in the digital engagement platform market.
- Rapid technological advancements that could render Spectrum DNA's products obsolete.
- Changing consumer preferences that could impact the demand for Spectrum DNA's services.
- Economic downturns that could reduce advertising spending and impact revenue.
- Limited financial resources that could hinder the company's ability to invest in growth opportunities.
What Are the Growth Opportunities for SPXA?
- Expansion of 'Enginet' Applications: Spectrum DNA can expand its suite of 'enginet' applications to cater to a broader range of media outlets and brand advertisers. By developing specialized enginets for specific industries or marketing campaigns, the company can increase its market reach and revenue potential. The market for digital engagement platforms is projected to reach $50 billion by 2028, offering significant growth opportunities for innovative solutions like those offered by Spectrum DNA. Timeline: 1-2 years.
- Strategic Partnerships with Media Outlets: Forming strategic partnerships with media outlets can provide Spectrum DNA with access to a larger audience and increased brand visibility. By integrating its enginets into existing media platforms, the company can drive user engagement and generate revenue through advertising and subscription models. The media industry is increasingly focused on enhancing user experiences, creating a favorable environment for collaborative ventures. Timeline: 6-12 months.
- Development of AI-Powered Engagement Tools: Investing in the development of AI-powered engagement tools can enhance the functionality and effectiveness of Spectrum DNA's enginets. By leveraging artificial intelligence, the company can personalize user experiences, optimize marketing campaigns, and automate content delivery. The market for AI in marketing is expected to reach $40 billion by 2027, presenting a significant growth opportunity for companies that can effectively integrate AI into their offerings. Timeline: 2-3 years.
- Geographic Expansion into Emerging Markets: Expanding its geographic reach into emerging markets can provide Spectrum DNA with access to new customer segments and increased revenue streams. By adapting its enginets to local languages and cultural preferences, the company can tap into the growing demand for digital engagement platforms in these regions. Emerging markets are experiencing rapid growth in internet penetration and social media adoption, creating a favorable environment for expansion. Timeline: 3-5 years.
- Monetization of User Data and Analytics: Spectrum DNA can monetize the user data and analytics generated by its enginets by offering targeted advertising and marketing services to its clients. By leveraging data-driven insights, the company can help its clients optimize their marketing campaigns and improve their return on investment. The market for data analytics in marketing is projected to reach $35 billion by 2026, offering significant revenue opportunities for companies that can effectively leverage user data. Timeline: 1-2 years.
What Opportunities Does SPXA Have?
- Expansion into emerging markets
- Strategic partnerships with media outlets
- Development of AI-powered engagement tools
- Monetization of user data
What Threats Does SPXA Face?
- Intense competition from established players
- Rapid technological advancements
- Changing consumer preferences
- Economic downturns
What Are SPXA's Competitive Advantages?
- Proprietary 'enginet' technology.
- Integrated social marketing platform.
- Customizable and contextual browser application.
- API for integrating gamification.
What Does SPXA Do?
Founded in 2006 and based in Park City, Utah, Spectrum DNA, Inc. operates as a social media studio specializing in the creation of digital networked applications, referred to as 'enginets.' These enginets are designed to drive engagement primarily for media outlets and brand advertisers. The company's core offerings include branded web and wireless-based network experiences, along with web and mobile applications. Spectrum DNA's principal enginets comprise The Addictionary, a social wordplay engine that serves as the foundation for word-related applications, and PlanetTagger, a location-enabled integrated social marketing platform. PlanetTagger provides online communities with tools to centralize social media marketing and editorial programming, while also offering users utilities to extend the community's reach. In addition to these core products, Spectrum DNA offers OptEngage, a configurable and contextual browser application that interacts with a cloud-based platform. This allows clients to deliver content and utility to their users on the web. The company also provides the Hucklemonkey, an application programming interface (API) that integrates gamification into clients' existing services or new applications. Spectrum DNA operates with a small team of 8 employees, led by Parrish Ketchmark.
What Products and Services Does SPXA Offer?
- Develop digital networked applications known as 'enginets'.
- Create branded web and wireless-based network experiences.
- Offer web and mobile applications for media outlets and brand advertisers.
- Provide The Addictionary, a social wordplay engine.
- Offer PlanetTagger, a location-enabled integrated social marketing platform.
- Provide OptEngage, a configurable and contextual browser application.
- Offer Hucklemonkey, an API that integrates gamification.
How Does SPXA Make Money?
- Develop and license 'enginets' to media outlets and brand advertisers.
- Generate revenue through advertising and subscription models.
- Offer data analytics and targeted marketing services.
- Monetize user data generated by its enginets.
What Industry Does SPXA Operate In?
Spectrum DNA, Inc. operates within the financial conglomerates industry, a segment characterized by diverse business activities and exposure to various market trends. The company's focus on digital engagement platforms places it at the intersection of social media, advertising technology, and online community development. The competitive landscape includes established social media giants, specialized advertising technology providers, and emerging digital marketing agencies. The industry is driven by the increasing demand for engaging online experiences, the growing adoption of social media marketing, and the continuous evolution of digital technologies. Spectrum DNA's success depends on its ability to innovate, differentiate its offerings, and effectively capture market share in this dynamic environment.
Who Are SPXA's Key Customers?
- Media outlets seeking to enhance user engagement.
- Brand advertisers looking to improve marketing campaign effectiveness.
- Online communities seeking to centralize social media marketing.
- Clients looking to integrate gamification into their services.
Company Profile
SpectrumDNA, Inc. operates in the Financial - Conglomerates industry within the Financial Services sector. It is headquartered in Park City, US. The company is led by CEO Parrish Ketchmark. SPXA has traded publicly since 2023.
SpectrumDNA, Inc. (SPXA) Valuation Context
Valued at 581K, SPXA is classified as a micro-cap stock. Relative to its peer group, SPXA's quantitative score of 54/100 is roughly in line with the peer average of 58/100.
SPXA Financials
Bull Case vs Bear Case
Bull Case
- Proprietary 'enginet' technology
- Integrated social marketing platform
- Customizable browser application
- API for gamification integration
Bear Case
- Limited financial resources
- Small team size
- Negative profitability
- High dependence on key clients
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
SPXA Latest News
No recent news available for SPXA.
SPXA Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for SPXA.
Price Targets
Wall Street price target analysis for SPXA.
SPXA MoonshotScore
What does this score mean?
The MoonshotScore rates SPXA's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Parrish Ketchmark
CEO
Parrish Ketchmark serves as the CEO of Spectrum DNA, Inc. His background includes experience in managing and developing digital engagement platforms. Ketchmark's expertise lies in creating innovative solutions for media outlets and brand advertisers. He is responsible for overseeing the company's strategic direction, product development, and business operations. His leadership is crucial for navigating the competitive landscape and driving growth.
Track Record: Under Parrish Ketchmark's leadership, Spectrum DNA, Inc. has focused on developing and expanding its suite of 'enginet' applications. He has overseen the launch of key products such as The Addictionary and PlanetTagger. His strategic decisions have aimed to enhance user engagement and generate revenue through advertising and subscription models. However, the company's financial performance remains a challenge.
SPXA OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Spectrum DNA, Inc. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not provide regular financial reporting, increasing the risk for investors. Investing in OTC Other stocks requires careful due diligence and an understanding of the associated risks, as these companies may be subject to less regulatory oversight than those listed on major exchanges like NYSE or NASDAQ.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure
- Low trading volume and liquidity
- Potential for price manipulation
- Higher risk of fraud or scams
- Limited regulatory oversight
- Verify the company's financial statements and disclosures.
- Research the background and experience of the management team.
- Assess the company's business model and competitive landscape.
- Evaluate the company's legal and regulatory compliance.
- Review the company's risk factors and potential liabilities.
- Check for any red flags or warning signs.
- Consult with a financial advisor or legal professional.
- Company has been in operation since 2006.
- Company has a registered business address in Park City, Utah.
- Company has a CEO and a team of 8 employees.
- Company has developed and launched several digital engagement platforms.
- Company has a gross margin of 97.1%.
Common Questions About SPXA (Financial Services)
What does SpectrumDNA, Inc. do?
SpectrumDNA, Inc. operates as a social media studio, creating digital networked applications, or 'enginets,' designed to enhance user engagement for media outlets and brand advertisers. Their offerings include The Addictionary, a social wordplay engine, and PlanetTagger, a location-enabled integrated social marketing platform. The company also provides OptEngage, a configurable browser application, and Hucklemonkey, an API for integrating gamification. SpectrumDNA aims to provide innovative solutions for clients seeking to improve their digital presence and user interaction.
What do analysts say about SPXA stock?
As of March 17, 2026, there is no available analyst coverage or consensus on SPXA stock. Given its OTC Other listing and limited market capitalization, the stock is unlikely to be actively tracked by major research firms. Investors should conduct their own thorough due diligence and consider the inherent risks associated with investing in micro-cap, OTC-listed companies. Key valuation metrics, such as price targets and earnings estimates, are not available due to the lack of analyst coverage.
What are the main risks for SPXA?
The main risks for SpectrumDNA, Inc. include its OTC Other listing, which implies limited financial disclosure and regulatory oversight. The company faces intense competition in the digital engagement platform market, and rapid technological advancements could render its products obsolete. Additionally, changing consumer preferences and economic downturns could impact demand for its services. The company's limited financial resources and small team size also pose challenges to its growth prospects. Investors should carefully consider these risks before investing in SPXA.
What are the key factors to evaluate for SPXA?
SpectrumDNA, Inc. (SPXA) holds an AI score of 54/100 (moderate). Not financial advice.
How frequently does SPXA data refresh on this page?
SPXA prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven SPXA's recent stock price performance?
SpectrumDNA, Inc. (SPXA) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Proprietary 'enginet' technology. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider SPXA overvalued or undervalued right now?
Valuing SpectrumDNA, Inc. (SPXA) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying SPXA?
Before investing in SpectrumDNA, Inc. (SPXA), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data as of March 17, 2026.
- OTC market data may be limited or unreliable.
- Lack of analyst coverage increases uncertainty.